AI helps to evaluate skin lesions in rare disease more accurately

There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial intelligence to quantitatively measure for the…

Continue Reading

News Source: medicalxpress.com